Frank de Vocht

Prof. Frank de Vocht

University of Bristol
orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2012 in Atmospheric Environment
Verified
Journal Article
Closed access
Marloes EeftensMarloes Eeftens
Marloes Eeftens
MTMing-Yi Tsai
Ming-Yi Tsai
CAChristophe Ampe
Christophe Ampe
BABernhard Anwander
Bernhard Anwander
RBRob Beelen
Rob Beelen
GHGerard Hoek
Gerard Hoek

1 December 2012 in Atmospheric Environment
Verified
Journal Article
Closed access
JCJosef Cyrys
Josef Cyrys
Marloes EeftensMarloes Eeftens
Marloes Eeftens
Joachim HeinrichJoachim Heinrich
Joachim Heinrich
CAChristophe Ampe
Christophe Ampe
AAAlexandre Armengaud
Alexandre Armengaud
GHGerard Hoek
Gerard Hoek

25 September 2017 in Cochrane Database of Systematic Reviews
Verified
Journal Article
Closed access
PDF file
EKEileen Fs Kaner
Eileen Fs Kaner
FBFiona Beyer
Fiona Beyer
CGClaire Garnett
Claire Garnett
DCDavid Crane
David Crane
JBJamie Brown
Jamie Brown
SMSusan Michie
Susan Michie

1 January 2014 in Environmental Health Perspectives
Verified
Journal Article
Open access
EMElaina A. MacIntyre
Elaina A. MacIntyre
UGUlrike Gehring
Ulrike Gehring
Anna MölterAnna Mölter
Anna Mölter
Elaine FuertesElaine Fuertes
Elaine Fuertes
CKClaudia Klümper
Claudia Klümper
Joachim HeinrichJoachim Heinrich
Joachim Heinrich
Background: Few studies have investigated traffic-related air pollution as a risk factor for respiratory infections during early childhood.Objectives: We aimed to investigate the association between air pollution and pneumonia, croup, and otitis media in 10 European birth cohorts—BAMSE (Sweden), GASPII (Italy), GINIplus and LISAplus (Germany), MAAS (United Kingdom), PIAMA (the Netherlands), and four INMA cohorts (Spain)—and to derive combined effect estimates using meta-analysis.Methods: Parent report of physician-diagnosed pneumonia, otitis media, and croup during early childhood were assessed in relation to annual average pollutant levels [nitrogen dioxide (NO2), nitrogen oxide (NOx), particulate matter ≤ 2.5 μm (PM2.5), PM2.5 absorbance, PM10, PM2.5–10 (coarse PM)], which were estimated using land use regression models and assigned to children based on their residential address at birth. Identical protocols were used to develop regression models for each study area as part of the ESCAPE project. Logist...

1 March 2021 in Social Science & Medicine
Verified
Journal Article
Open access
EMElizabeth McGill
Elizabeth McGill
VEVanessa Er
Vanessa Er
TPTarra Penney
Tarra Penney
MEMatt Egan
Matt Egan
MWMartin White
Martin White
MPMark Petticrew
Mark Petticrew
Applying a complex systems perspective to public health evaluation may increase the relevance and strength of evidence to improve health and reduce health inequalities. In this review of methods, we aimed to: (i) classify and describe different complex systems methods in evaluation applied to public health; and (ii) examine the kinds of evaluative evidence generated by these different methods. We adapted critical review methods to identify evaluations of public health interventions that used systems methods. We conducted expert consultation, searched electronic databases (Scopus, MEDLINE, Web of Science), and followed citations of relevant systematic reviews. Evaluations were included if they self-identified as using systems- or complexity-informed methods and if they evaluated existing or hypothetical public health interventions. Case studies were selected to illustrate different types of complex systems evaluation. Seventy-four unique studies met our inclusion criteria. A framework was developed to map the included studies onto different stages of the evaluation process, which parallels the planning, delivery, assessment, and further delivery phases of the interventions they seek to inform; these stages include: 1) theorising; 2) prediction (simulation); 3) process evaluation; 4) impact evaluation; and 5) further prediction (simulation). Within this framework, we broadly categorised methodological approaches as mapping, modelling, network analysis and 'system framing' (the application of a complex systems perspective to a range of study designs). Studies frequently applied more than one type of systems method. A range of complex systems methods can be utilised, adapted, or combined to produce different types of evaluative evidence. Further methodological innovation in systems evaluation may generate stronger evidence to improve health and reduce health inequalities in our complex world.

12 February 2014 in American Journal of Hematology
Verified
Journal Article
Open access
PDF file
GTGlen J. Titmarsh
Glen J. Titmarsh
ADAndrew S. Duncombe
Andrew S. Duncombe
MMMary Frances McMullin
Mary Frances McMullin
MOMichael O'Rorke
Michael O'Rorke
RMRuben Mesa
Ruben Mesa
LALesley A. Anderson
Lesley A. Anderson
Myeloproliferative neoplasms (MPNs) are a heterogeneous group of diseases including polycythemia vera (PV), essential thrombocythemia (ET), and primary(idiopathic) myelofibrosis (PMF). In this systematic review, we provide a comprehensive report on the incidence and prevalence of MPNs across the globe. Electronic databases (PubMed, EMBASE, MEDLINE, and Web of Science) were searched from their inception to August 2012 for articles reporting MPN incidence or prevalence rates. A random effects meta‐analysis was undertaken to produce combined incidence rates for PV, ET, and PMF. Both heterogeneity and small study bias were assessed. Thirty‐four studies were included. Reported annual incidence rates ranged from 0.01 to 2.61, 0.21 to 2.27, and 0.22 to 0.99 per 100,000 for PV, ET, and PMF, respectively. The combined annual incidence rates for PV, ET, and PMF were 0.84, 1.03, and 0.47 per 100,000. There was high heterogeneity across disease entities (I2 97.1–99.8%) and evidence of publication bias for ET and PMF (Egger test, P = 0.007 and P ≤ 0.001, respectively).The pooled incidence reflects the rarity of MPNs. The calculated pooled incidence rates do not reflect MPN incidence across the globe due to the high unexplained heterogeneity. Improved, widespread registration of MPNs would provide better information for global comparison of the incidence and prevalence of MPNs. Am. J. Hematol. 89:581–587, 2014.